On Oct. 6, The Wall Street Journal reported that activist investor group Starboard Value owns a stake in Pfizer ( PFE -0.61%) ...
Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...
Pfizer Inc. (PFE) announced Friday that the U.S. Food and Drug Administration has approved HYMPAVZI (marstacimab-hncq) for routine ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Pfizer (PFE) stock slips as former executives Ian Read and Frank D'Amelio exit Starboard Value's activist campaign against ...
Leerink Partners analyst David Risinger has maintained their neutral stance on PFE stock, giving a Hold rating on October 7. David ...
Park Place Capital Corp cut its position in Pfizer Inc. (NYSE:PFE – Free Report) by 15.5% in the 3rd quarter, according to ...
U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Monday. Shares of Pfizer Inc PFE rose during ...
Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...
U.S. stock indexes fell on Thursday amid unexpected inflation and jobless claim figures. The Consumer Price Index increased ...
In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Pfizer (PFE – Research Report), with a price ...